Skip to main content
. 2022 Apr 7;12:852809. doi: 10.3389/fonc.2022.852809

Table 1.

General status of subjects.

Group PP GP t/χ2 p
Number 42 41
Age 53.02 ± 9.64 52.59 ± 9.46 −0.209 0.835
HR
Negative 22 13 3.636 0.057
Positive 20 28
HER2
3+ 32 31 0.004 0.951
2+ FISH positive 10 10
Physical status (ZPS)
<2 41 41 1
≥2 1 0
Previous use of chemotherapeutic drugs
Paclitaxel 32 31 0.004 0.951
Anthracycline 33 27 1.675 0.196
Cyclophosphamide 28 23 0.978 0.323
Recurrence or metastasis within 12 months after (adjuvant) chemotherapy
Yes 16 12 0.725 0.696
No 16 18
 – 10 11
Liver metastasis was initially diagnosed
Yes 10 10 0.004 0.951
No 32 31